TRANSFAR ZHILIAN(002010)
Search documents
传化智联(002010.SZ):涂料业务暂无可应用于航空航天的相关产品
Ge Long Hui· 2026-01-19 07:08
格隆汇1月19日丨传化智联(002010.SZ)在投资者互动平台表示,截止目前,公司涂料业务暂无可应用于 航空航天的相关产品。 ...
传化智联:公司及控股子公司无逾期的担保
Zheng Quan Ri Bao Wang· 2026-01-16 15:16
证券日报网讯1月16日,传化智联(002010)发布公告称,截至2026年1月15日,公司(含控股子公司)的 累计担保总额为218097.13万元(其中,开展资产池业务发生互保总额为0万元,开展票据池业务发生互 保总额为5186.89万元),占公司2024年度经审计总资产的5.21%,占公司2024年度经审计净资产的 12.64%。公司及控股子公司无逾期的担保、涉及诉讼的担保及因担保被判决败诉而应承担损失的情 形。 ...
传化智联(002010) - 关于提供担保的进展公告
2026-01-16 08:15
证券代码:002010 证券简称:传化智联 公告编号:2026-006 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假 记载、误导性陈述或重大遗漏。 一、担保预计概述 传化智联股份有限公司(以下简称"公司")于 2025 年 4 月 18 日召开第八 届董事会第二十七次会议、2025 年 5 月 20 日召开 2024 年年度股东大会,审议 通过了《关于 2025 年度提供担保额度预计的议案》,为满足子公司日常运营和 项目建设资金需要,保证公司业务顺利开展,同意公司为子公司提供总计不超过 473,000.00 万元人民币的担保额度,其中为资产负债率低于 70%的子公司提供担 保的额度不超过 368,000.00 万元人民币,为资产负债率高于 70%的子公司提供担 保的额度不超过 105,000.00 万元人民币。本次担保额度有效期为自 2024 年年度 股东大会审议通过之日起至 2025 年年度股东会召开之日止。 具体内容详见公司刊登于《证券时报》及巨潮资讯网的《关于 2025 年度提 供担保额度预计的公告》(公告编号:2025-023)。 二、担保进展情况 近日,公司与交通银行股份有限公 ...
物流板块1月15日涨1.05%,德邦股份领涨,主力资金净流入1.74亿元
Zheng Xing Xing Ye Ri Bao· 2026-01-15 08:59
Market Overview - The logistics sector increased by 1.05% on January 15, with Debon Holdings leading the gains [1] - The Shanghai Composite Index closed at 4112.6, down 0.33%, while the Shenzhen Component Index closed at 14306.73, up 0.41% [1] Individual Stock Performance - Debon Holdings (603056) closed at 16.98, up 9.97% with a trading volume of 15,200 [1] - Jiayou International (603871) closed at 14.42, up 3.30% with a trading volume of 185,000 [1] - Tiens Holdings (002800) closed at 17.31, up 3.22% with a trading volume of 113,900 [1] - YTO Express (600233) closed at 17.05, up 2.59% with a trading volume of 335,000 [1] - SF Holding (002352) closed at 39.19, up 1.66% with a trading volume of 474,100 [1] Capital Flow Analysis - The logistics sector saw a net inflow of 174 million yuan from institutional investors, while retail investors experienced a net outflow of 80.49 million yuan [2] - Major stocks like SF Holding had a net inflow of 164 million yuan from institutional investors, indicating strong institutional interest [3] - Debon Holdings had a significant institutional net inflow of 15.11 million yuan, representing 58.69% of its trading volume [3]
传化智联涨2.47%,成交额2.56亿元,主力资金净流出204.76万元
Xin Lang Cai Jing· 2026-01-15 06:25
Core Viewpoint - The stock of Transfar Zhilian has shown a positive trend with a year-to-date increase of 14.46%, driven by its diverse business operations in specialized chemicals and logistics [1][2]. Group 1: Stock Performance - On January 15, Transfar Zhilian's stock rose by 2.47%, reaching 6.65 CNY per share, with a trading volume of 256 million CNY and a turnover rate of 1.43%, resulting in a total market capitalization of 18.381 billion CNY [1]. - The stock has experienced a 7.61% increase over the last five trading days, a 17.91% increase over the last 20 days, and a 2.15% increase over the last 60 days [1]. Group 2: Financial Performance - For the period from January to September 2025, Transfar Zhilian reported a revenue of 18.840 billion CNY, reflecting a year-on-year decrease of 2.74%, while the net profit attributable to shareholders increased by 168.36% to 637 million CNY [2]. - The company has distributed a total of 3.348 billion CNY in dividends since its A-share listing, with 969 million CNY distributed over the last three years [3]. Group 3: Shareholder Information - As of September 30, 2025, the number of shareholders for Transfar Zhilian reached 48,800, an increase of 11.63% from the previous period, with an average of 57,044 circulating shares per shareholder, a decrease of 10.42% [2]. - Among the top ten circulating shareholders, Hong Kong Central Clearing Limited holds 29.4105 million shares, an increase of 7.0294 million shares from the previous period [3].
蚂蚁数科与杭州具身智能中试基地达成合作意向 推动具身智能商业化落地
Zheng Quan Shi Bao Wang· 2026-01-15 06:00
人民财讯1月15日电,1月14日,蚂蚁数字科技具身机器人技术负责人吕丹带队到访杭州具身智能中试基 地科技有限公司,与基地公司围绕"共建数智引擎、赋能千行百业"展开深度交流。双方就"场景驱动、 开源共振、产业共生"达成合作意向,共同展望在具身智能领域的协同发展。双方一致认为,推动具身 智能技术走出实验室、实现商业化落地,是响应国家"人工智能+"行动、培育新质生产力的重要举措。 资料显示,杭州具身智能中试基地发起的四大股东包括传化智联(002010)、杭州高新科创集团、杭州 市数据集团、杭州宇树机器人有限公司。 ...
财经聚焦·对话企业掌门人丨一家40年的企业如何常青?——对话传化集团有限公司董事长徐冠巨
Xin Hua Wang· 2026-01-14 04:23
近期,传化集团的技术实力与产业化能力再次得到认可,由这家民营企业与国有资本合作建设运营的"杭州合成生物产业中试(验证)中 心",入选首批生物制造中试能力建设平台名单。 从1986年创业至今,传化集团已成长为中国500强企业,业务覆盖功能化学品、新材料、物流、科技城、农业等领域。其功能化学品聚焦专精 特新,有超过8000种产品,服务纺织、造纸、半导体、新能源等20多个行业。 "企业如何在一次次市场变化中,通过自我迭代实现转型升级和高质量发展?""面对人工智能等快速演进的新技术和全球化浪潮,企业怎样抓 住发展新机遇?""扎实推进乡村全面振兴、全体人民共同富裕,民营企业应扮演怎样的角色?"结合企业的探索实践,传化集团董事长徐冠巨将一 路稳健发展的思考和感悟娓娓道来。 "做好适应趋势、进而引领趋势的充分准备" 位于钱塘江边的传化大厦,以"拥抱AI科技革命"为主题的一场场研讨、培训、合作交流正如火如荼进行着。记者在这里见到了徐冠巨。 作为一家知名民企,传化集团的动向颇受关注。"2025年刚刚过去,这一年传化集团有了哪些新进展、新变化?"记者抛出第一个问题。 "2025年1至11月,传化集团营业总收入实现1298.05亿 ...
财经聚焦·对话企业掌门人|一家40年的企业如何常青?——对话传化集团有限公司董事长徐冠巨
Sou Hu Cai Jing· 2026-01-14 04:22
Core Viewpoint - Transfar Group has been recognized for its technological strength and industrialization capabilities, marking its growth as a leading private enterprise in China with a focus on high-quality development and innovation in various sectors [7][8]. Group 1: Company Overview - Transfar Group, founded in 1986, has become one of China's top 500 enterprises, with a diverse business portfolio including functional chemicals, new materials, logistics, technology parks, and agriculture [7]. - The company offers over 8,000 products, serving more than 20 industries such as textiles, papermaking, semiconductors, and new energy [7]. Group 2: Financial Performance - In the period from January to November 2025, Transfar Group achieved a total revenue of 129.805 billion yuan, reflecting a year-on-year growth of 5.29% [8]. Group 3: Strategic Focus - The company emphasizes product innovation, platform innovation, and industrial ecosystem innovation rather than merely pursuing scale and volume growth [8]. - Transfar Group prioritizes three key elements for high-quality development: talent, technology, and management, with a strong focus on continuous investment in innovation [9]. Group 4: Technological Advancements - The company has developed its proprietary AI model, "Transfar Xiaozhi," and is implementing AI systems across 58 scenarios in 12 major fields, including manufacturing, logistics, chemicals, and agriculture [14]. - Transfar has established a global presence, with products sold in over 130 countries and regions, and overseas sales accounting for 25% of its manufacturing output [18]. Group 5: Social Responsibility - Transfar Group actively engages in rural revitalization and social responsibility, exemplified by the establishment of the Xie Jing'an Transfar Agricultural Innovation Village, which has fostered nearly 50 agricultural innovation enterprises and generated significant economic benefits for local communities [19][21].
物流板块1月13日跌0.53%,龙洲股份领跌,主力资金净流出4.19亿元
Zheng Xing Xing Ye Ri Bao· 2026-01-13 09:00
Core Viewpoint - The logistics sector experienced a decline of 0.53% on January 13, with Longzhou Co. leading the drop. The Shanghai Composite Index closed at 4138.76, down 0.64%, while the Shenzhen Component Index closed at 14169.4, down 1.37% [1]. Group 1: Market Performance - The logistics sector saw individual stock performances with notable gainers such as Jushen Co. (up 10.02% to 19.44) and Pulutong (up 10.00% to 13.75) [1]. - Longzhou Co. led the decline with a drop of 9.94% to 7.79, followed by Xiamen Xiangyu (down 2.84% to 8.22) and Xiamen Guomao (down 2.36% to 7.04) [2]. Group 2: Trading Volume and Value - Jushen Co. had a trading volume of 229,200 shares and a transaction value of 441 million yuan, while Pulutong had a volume of 468,300 shares and a value of 618 million yuan [1]. - Longzhou Co. recorded a trading volume of 1,475,900 shares with a transaction value of 1.206 billion yuan, indicating significant trading activity despite the decline [2]. Group 3: Capital Flow - The logistics sector experienced a net outflow of 419 million yuan from institutional investors, while retail investors saw a net inflow of 380 million yuan [2]. - Individual stocks like Pulutong had a net inflow of 64.9 million yuan from institutional investors, while Jushen Co. saw a net inflow of 35.9 million yuan [3].
逾百家A股公司预告2025年业绩 科技与生物医药行业增长强劲
Shang Hai Zheng Quan Bao· 2026-01-12 18:35
Core Insights - Approximately 130 A-share companies have disclosed their performance forecasts for 2025, with around 70 companies expecting positive results, including profit increases and turnaround from losses [2][4]. Company Performance Highlights - **Zhongke Lanyun**: Expected net profit of 1.4 billion to 1.43 billion yuan, a year-on-year increase of 366.51% to 376.51%, driven by strategic investments in high-growth areas like GPU and advanced packaging [4][5]. - **Chuanhua Zhili**: Forecasted net profit of 540 million to 700 million yuan, with a growth rate of 256.07% to 361.57%, supported by optimized marketing strategies and asset structure in logistics and chemical businesses [5]. - **Bai'ao Saitou**: Anticipated net profit of 135 million yuan, reflecting a 303.57% increase, attributed to favorable market conditions [4]. - **Kangchen Pharmaceutical**: Expected net profit of 145 million to 175 million yuan, with a growth of 243% to 315%, due to the absence of goodwill impairment losses in the reporting period [5]. - **Guangku Technology**: Projected net profit of 169 million to 182 million yuan, a growth of 152% to 172%, driven by product innovation and cost control [7]. - **Lixun Precision**: Forecasted net profit of 16.518 billion to 17.186 billion yuan, with a growth of 23.59% to 28.59%, supported by innovations in manufacturing and AI integration [6]. - **Daotong Technology**: Expected net profit of 900 million to 930 million yuan, with a growth of 40.42% to 45.10%, driven by AI-driven services [6]. - **Aibisen**: Anticipated net profit of 240 million to 290 million yuan, reflecting a growth of 105.32% to 148.09%, due to increased R&D investment [7]. - **Chaohongji**: Expected net profit of 436 million to 533 million yuan, with a growth of 125% to 175%, supported by a focus on brand optimization and digital transformation [9]. - **WuXi AppTec**: Forecasted net profit of 19.151 billion yuan, with a growth of approximately 102.65%, including gains from divesting joint ventures [9]. - **Hui Sheng Biological**: Expected net profit of 23.5 million to 27.1 million yuan, indicating a turnaround, driven by market expansion and improved production efficiency [9]. Industry Performance Insights - The electronics, semiconductor, pharmaceutical, and machinery sectors are showing strong performance among listed companies [3].